Healthy Adults Clinical Trial
Official title:
Stimulating the Social Brain
NCT number | NCT03374631 |
Other study ID # | 17-126 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | December 1, 2017 |
Est. completion date | October 1, 2020 |
Verified date | March 2023 |
Source | The University of Texas at Dallas |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study investigates whether the way in which individuals process social stimuli can be altered, and specifically, whether feelings of paranoia and suspiciousness can be reduced by stimulating the brain's regulatory regions via transcranial Direct Current Stimulation (tDCS).
Status | Completed |
Enrollment | 40 |
Est. completion date | October 1, 2020 |
Est. primary completion date | October 1, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: - between the ages of 18 ad 35 - previous classification as being high in sub-clinical paranoia Exclusion Criteria: - diagnosis of mental illness - use of psychotropic medication - Presence or history of medical, cardiac, or neurological disorders that may affect brain function (e.g., cardiac disease, endocrine disorders, renal disease, pulmonary disease, history of seizures or head trauma with unconsciousness for a period of 15 minutes or greater or CNS tumors) - Presence of sensory limitation including visual (e.g., blindness, glaucoma, vision uncorrectable to 20/40) or hearing (e.g. hearing loss) impairments that interfere with assessment - Not proficient in English - Contraindications for tDCS (e.g., pregnancy or implanted devices such as pace maker) |
Country | Name | City | State |
---|---|---|---|
United States | The Unversity of Texas at Dallas | Richardson | Texas |
Lead Sponsor | Collaborator |
---|---|
The University of Texas at Dallas |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in General Paranoid Ideation for Active vs. Sham Simulation | Level of paranoid ideation will be assessed with the self-report Paranoia Scale (PS; Fenigstein & Vanable, 1992) both before and after tDCS to assess changes related to tDCS. The PS is a self-report measure designed to assess sub-clinical paranoid thought. Scores range from 20-100 with higher scores indicating higher levels of paranoia. The amount of pre-post change (i.e. PS score assessed before stimulation minus score after stimulation) is the primary value of interest and will be compared between active and sham stimulation. Improvements in paranoia will be indicated by positive values. | Paranoid ideation will be assessed 30 minutes after completion of the active/sham stimulation | |
Primary | Change in Change in Social Paranoia for Active vs. Sham Simulation | Level of paranoid ideation will be assessed with the persecution subscale of the State Social Paranoia Scale (SSPS: Freeman et al., 2007) both before and after tDCS to assess changes related to tDCS. The SSPS is a psychometrically sound 20-item self- report measure assessing current levels of paranoid, positive, and neutral thinking about others. Ten items comprise the persecution subscale, and scores on this subscale range from 10-50 with higher scores indicating greater paranoia. The amount of pre-post change (i.e.SSPS score before stimulation minus SSPS score after stimulation) will be compared between active and sham stimulation. Positive values indicate reductions in paranoia after stimulation. | Paranoid ideation will be assessed 30 minutes after completion of the active/sham stimulation | |
Secondary | Trustworthiness Task Score for Active vs. Sham Stimulation | Participants will complete the Trustworthiness Task (Adolphs, Tranel, & Damasio, 1998), which asks individuals to view 42 images of others and rate their level of trustworthiness on a scale from -3 to 3. Scores range from -126 to 126. Higher scores indicate greater perceptions of trustworthiness. Mean ratings following each stimulation type (active vs. sham) are calculated. | assessed 30 minutes after completion of the active/sham stimulation | |
Secondary | Penn Emotion Recognition Test for Active vs. Sham Stimulation | The Emotion Recognition 40 (ER-40; Kohler, Turner, Bilker, Brinsinger, Siegel, Kanes... Gur, 2003) is a standardized, computer administered measure of facial affect recognition ability. It includes 40 color photographs of faces expressing 4 basic emotions (i.e. happiness, sadness, anger or fear) and neutral expressions. Participants view one face at a time and are asked to choose the correct emotion for each face. Scores range from 0-40 with higher scores indicating better accuracy. Mean performance following each stimulation type (active vs. sham) are calculated. | assessed 30 minutes after completion of the active/sham stimulation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04677920 -
The Healthy Cookie Energy Study: Understanding How Healthy Cookies Affect Mitochondrial Biology
|
N/A | |
Active, not recruiting |
NCT03312920 -
Investigating Memory Retrieval Improvement in Healthy Subjects
|
N/A | |
Completed |
NCT03309072 -
Investigating Accelerated Learning and Memory in Healthy Subjects Using a Face Name Memory Task
|
N/A | |
Completed |
NCT03289832 -
Effect of Orally Delivered Phytochemicals on Aging and Inflammation in the Skin
|
N/A | |
Enrolling by invitation |
NCT06133530 -
Human Milk Oligosaccharides (HMOs) and Gut Microbiota, Immune System in Antarctica
|
N/A | |
Completed |
NCT05141903 -
Dietary Supplement With and Without a Probiotic and/or Antibiotic
|
||
Completed |
NCT01689259 -
Comparative Pharmacokinetics and Safety of TNX-102 SL Tablets and Cyclobenzaprine Oral Tablet in Healthy Adults
|
Phase 1 | |
Completed |
NCT01187875 -
Resistant Starch and Satiety
|
Phase 0 | |
Completed |
NCT03312699 -
Effects of Aging on Primary and Secondary Vaccine Responses in a 15-Year Longitudinal Cohort
|
Phase 1 | |
Completed |
NCT03319134 -
Investigating the Neural Correlates in Memory Retrieval After HD-tDCS
|
N/A | |
Recruiting |
NCT04104360 -
Galacto-oligosaccharides and Intestinal Activity
|
N/A | |
Completed |
NCT03228693 -
Gene Expression and Biomarker Profiling of Keloid Skin
|
N/A | |
Completed |
NCT04206293 -
A Study to Evaluate The Impact on Skin Quality Attributes by Juvederm® Volite Injection on Healthy Volunteers
|
N/A | |
Completed |
NCT04146532 -
Aspirin Effects on Emotional Reactions
|
Early Phase 1 | |
Recruiting |
NCT06011018 -
Comparison of Effects of Mirror Therapy Combined With Neuromuscular Electrical Stimulation or Binaural Beats Stimulation on Cortical Excitability, Heart Rate Variability and Lower Limb Motor Function in Patients With Stroke
|
N/A | |
Completed |
NCT05093205 -
STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS
|
Phase 1 | |
Completed |
NCT04596709 -
Investigation of Blood Glucose and Insulin Response After Intake of Vitalose
|
N/A | |
Completed |
NCT04272450 -
Respiratory Muscle Strength in Different Age Groups
|
||
Completed |
NCT02044679 -
Evaluation of Spot Urine as a Biomarker of Fluid Intake in Real Life Conditions
|
N/A | |
Completed |
NCT01402973 -
Pilot Study of a Dietary Intervention Based Upon Advanced Glycation End Products
|
N/A |